| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T10 |
0-73 |
Sentence |
denotes |
Table 1 Characteristics between survivors and non-survivors with COVID-19 |
| T11 |
74-182 |
Sentence |
denotes |
Characteristics Total (n = 44,672) Non-survivors (n = 1023) Survivors (n = 43,649) Fatality (%) RR (95%CI) p |
| T12 |
183-193 |
Sentence |
denotes |
Age, n (%) |
| T13 |
194-223 |
Sentence |
denotes |
0– 416 (0.9%) 0 416 (0.9%) 0 |
| T14 |
224-263 |
Sentence |
denotes |
10– 549 (1.2%) 1 (0.1%) 548 (1.3%) 0.2 |
| T15 |
264-305 |
Sentence |
denotes |
20– 3619 (8.1%) 7 (0.7%) 3612 (8.3%) 0.2 |
| T16 |
306-350 |
Sentence |
denotes |
30– 7600 (17.0%) 18 (1.8%) 7582 (17.4%) 0.2 |
| T17 |
351-395 |
Sentence |
denotes |
40– 8571 (19.2%) 38 (3.7%) 8533 (19.5%) 0.4 |
| T18 |
396-444 |
Sentence |
denotes |
50– 10,008 (22.4%) 130 (12.7%) 9878 (22.6%) 1.3 |
| T19 |
445-491 |
Sentence |
denotes |
60– 8583 (19.2%) 309 (30.2%) 8274 (19.0%) 3.6 |
| T20 |
492-536 |
Sentence |
denotes |
70– 3918 (8.8%) 312 (30.5%) 3606 (8.3%) 8.0 |
| T21 |
537-583 |
Sentence |
denotes |
≥ 80 1408 (3.2%) 208 (20.3%) 1200 (2.7%) 14.8 |
| T22 |
584-600 |
Sentence |
denotes |
Severity*, n (%) |
| T23 |
601-649 |
Sentence |
denotes |
Mild/moderate 36,160 (80.9%) 0 36,160 (82.8%) 0 |
| T24 |
650-687 |
Sentence |
denotes |
Severe 6168 (13.8%) 0 6168 (14.1%) 0 |
| T25 |
688-738 |
Sentence |
denotes |
Critical 2087 (4.7%) 1023 (100%) 1064 (2.4%) 49.0 |
| T26 |
739-752 |
Sentence |
denotes |
Gender, n (%) |
| T27 |
753-829 |
Sentence |
denotes |
Male 22,981 (51.4%) 653 (63.8%) 22,328 (51.2%) 2.8 1.67 (1.47–1.89) < 0.001 |
| T28 |
830-883 |
Sentence |
denotes |
Female 21,691 (48.6%) 370 (36.2%) 21,321 (48.8%) 1.7 |
| T29 |
884-903 |
Sentence |
denotes |
Comorbidity#, n (%) |
| T30 |
904-984 |
Sentence |
denotes |
Hypertension 2683 (12.8%) 161 (39.7%) 2522 (12.3%) 6.0 4.48 (3.69–5.45) < 0.001 |
| T31 |
985-1058 |
Sentence |
denotes |
Diabetes 1102 (5.3%) 80 (19.7%) 1022 (5.0%) 7.3 4.47 (3.49–5.61) < 0.001 |
| T32 |
1059-1145 |
Sentence |
denotes |
Cardiovascular disease 873 (4.2%) 92 (22.7%) 781 (3.8%) 10.5 6.75 (5.40–8.43) < 0.001 |
| T33 |
1146-1227 |
Sentence |
denotes |
Respiratory disease 511 (2.4%) 32 (7.9%) 479 (2.3%) 6.3 3.43 (2.42–4.87) < 0.001 |
| T34 |
1228-1293 |
Sentence |
denotes |
Cancer 107 (0.5%) 6 (1.5%) 101 (0.5%) 5.6 2.93 (1.34–6.41) 0.006 |
| T35 |
1294-1336 |
Sentence |
denotes |
*Missing data (n = 257 in survivors group) |
| T36 |
1337-1422 |
Sentence |
denotes |
#Missing data (n = 617 in the non-survivors group, n = 23,073 in the survivors group) |
